AI-assisted versus conventional reading in pan-intestinal capsule endoscopy

The comparison between AI-assisted pan-intestinal capsule endoscopy (AI-PCE) and conventional reading of pan-intestinal capsule endoscopy (CR-PCE) highlights significant advancements in the diagnostic capabilities of AI technology in the context of suspected mid-lower gastrointestinal bleeding (MLGIB). Here’s a detailed breakdown:

### Overview of Pan-Intestinal Capsule Endoscopy (PCE)

PCE is a minimally invasive diagnostic tool used to evaluate the gastrointestinal (GI) tract, particularly for detecting potentially haemorrhagic lesions (PHLs) in cases of suspected MLGIB. While effective, the traditional method of reading PCE (CR-PCE) is labor-intensive, time-consuming, and prone to variability and missed lesions due to human error.

### AI-Assisted PCE (AI-PCE)

AI-PCE employs artificial intelligence, specifically a convolutional neural network (CNN), to assist in detecting lesions within the GI tract. This technology automates the lesion detection process, potentially improving diagnostic accuracy and efficiency.

---

### Key Findings from the Study

#### 1. **Improved Sensitivity and Negative Predictive Value (NPV)**

AI-PCE demonstrated significantly higher sensitivity and NPV compared to CR-PCE:

• **Sensitivity**: AI-PCE achieved a sensitivity of 95% overall, compared to 67% for CR-PCE. This means AI-PCE was much more effective at detecting lesions.
• **Negative Predictive Value (NPV)**: AI-PCE had an NPV of 92% versus 63% for CR-PCE, indicating a reduced likelihood of missing lesions.

#### 2. **Performance by Intestinal Segment**

• **Small Bowel**:
• Sensitivity: 96% (AI-PCE) vs. 59% (CR-PCE).
• NPV: 97% (AI-PCE) vs. 76% (CR-PCE).
• **Colon**:
• Sensitivity: 90% (AI-PCE) vs. 68% (CR-PCE).
• NPV: 94% (AI-PCE) vs. 86% (CR-PCE).

#### 3. **Lesion Detection**

AI-PCE outperformed CR-PCE in detecting various lesion types:

• **Vascular Lesions**: 51% detection rate with AI-PCE vs. 33% with CR-PCE.
• **Ulcers/Erosions**: 16% detection rate with AI-PCE vs. 7% with CR-PCE.
• **Protuberant Lesions**: Comparable detection rates (5% vs. 4%).
• **Active Bleeding**: Comparable detection rates (7% vs. 7%).

#### 4. **Comparison with Colonoscopy**

AI-PCE also outperformed traditional colonoscopy:

• Sensitivity: 90% (AI-PCE) vs. 32% (colonoscopy).
• Positive Predictive Value (PPV): 100% (AI-PCE) vs. 65% (colonoscopy).
• NPV: 94% (AI-PCE) vs. 65% (colonoscopy).

---

### Advantages of AI-PCE Over CR-PCE and Colonoscopy

1. **Higher Diagnostic Accuracy**: AI-PCE provides significantly better sensitivity and NPV, reducing the risk of missed lesions.

2. **Minimally Invasive**: Unlike colonoscopy, PCE is non-invasive, making it a more comfortable option for patients.

3. **Consistency and Reliability**: AI reduces reader dependency, variability, and the likelihood of human error in lesion detection.

4. **Time Efficiency**: Automating the review process with AI can save time for clinicians.

---

### Implications for Research, Practice, and Policy

1. **Redefining Diagnostic Standards**: AI-PCE may become the first-line diagnostic tool for suspected MLGIB, reducing the reliance on invasive procedures like colonoscopy.

2. **Improved Patient Outcomes**: By reducing false negatives, AI-PCE can decrease the need for repeated procedures and enhance early detection of critical lesions.

3. **Integration of AI into Clinical Workflows**: The study supports the incorporation of AI into capsule endoscopy to improve diagnostic accuracy and efficiency.

4. **Future Research**: Further validation studies and cost-effectiveness analyses are necessary to confirm the widespread applicability of AI-PCE.

---

### Conclusion

AI-assisted PCE represents a significant advancement over conventional reading methods and even colonoscopy in the diagnosis of suspected MLGIB. With its superior sensitivity, reliability, and minimally invasive nature, AI-PCE has the potential to revolutionize the diagnostic approach to gastrointestinal bleeding and set a new standard for clinical practice. However, further research is needed to validate these findings and address the cost implications of integrating AI into routine diagnostic workflows.